FDA.reportPublic FDA data

Abilify Asimtufii 720 MG per 2.4 ML extended release Prefilled Syringe

RxCUI
2636640
RxNorm name
Abilify Asimtufii 720 MG per 2.4 ML extended release Prefilled Syringe
Display name
Abilify Asimtufii 720 MG per 2.4 ML extended release Prefilled Syringe
Full name
Abilify Asimtufii 720 MG per 2.4 ML extended release Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Abilify AsimtufiiARIPIPRAZOLEOtsuka America Pharmaceutical, Incda4c07fd-1130-4341-bb44-63acfa4162be2025-04-04Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2636640

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
da4c07fd-1130-4341-bb44-63acfa4162beAbilify Asimtufii 720 MG per 2.4 ML extended release Prefilled SyringeSY6These highlights do not include all the information needed to use ABILIFY ASIMTUFII safely and effectively. See full prescribing information for ABILIFY ASIMTUFII. ABILIFY ASIMTUFII ® (aripiprazole) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200220250404
da4c07fd-1130-4341-bb44-63acfa4162be2.4 ML Abilify 300 MG/ML Prefilled SyringeSY6These highlights do not include all the information needed to use ABILIFY ASIMTUFII safely and effectively. See full prescribing information for ABILIFY ASIMTUFII. ABILIFY ASIMTUFII ® (aripiprazole) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200220250404
da4c07fd-1130-4341-bb44-63acfa4162beAbilify Asimtufii 720 MG in 2.4 ML Extended Release Prefilled SyringePSN6These highlights do not include all the information needed to use ABILIFY ASIMTUFII safely and effectively. See full prescribing information for ABILIFY ASIMTUFII. ABILIFY ASIMTUFII ® (aripiprazole) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200220250404
da4c07fd-1130-4341-bb44-63acfa4162be2.4 ML aripiprazole 300 MG/ML Prefilled Syringe [Abilify]SBD6These highlights do not include all the information needed to use ABILIFY ASIMTUFII safely and effectively. See full prescribing information for ABILIFY ASIMTUFII. ABILIFY ASIMTUFII ® (aripiprazole) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200220250404